PDA - Parenteral Drug Association’s Post

“GLP-1 is projected to be a $100 billion market by 2030, indicating a substantial increase in syringe consumption.” says Cory Lewis, CEO, President, and Founder of INCOG BioPharma Services. Ahead of CDMO Live this week, Cory spoke to the PharmaSource podcast about why strategic thinking is crucial for success in this fast-moving landscape. 🎧 Listen to the full interview: https://lnkd.in/esj9YYAv “We’re not just planning for the immediate needs but looking one, two, even three years ahead. With our second and third production lines in the pipeline, we’re preparing for the long-term demands of the market.” Founded in June 2020, INCOG has secured FDA-approval and now establishes itself as a new force in contract manufacturing with a focus on sterile injectables. Despite the company only being four years old, INCOG’s leadership team brings decades of industry experience.  Cory says he has brought the ‘band back together’ by reuniting seasoned professionals to create a tier-one contract manufacturing organisation. INCOG’s investments in vial, syringe, and cartridge filling capabilities are “just the beginning” he says. “We’re also expanding into quality control, lab stability services, and eventually, auto-injector device assembly and final packaging. Our long-term site master plan outlines our ambition to not only enhance filling capacity, but also integrate additional business units to support commercial packaging and device assembly.” “Our first FDA approval, achieved less than eighteen months after production began, is a testament to our operational and quality excellence. This milestone was marked by an eight-day inspection with zero observations, a rare accomplishment in our industry.” --- Join INCOG at #CDMOLive this Thursday, for an exclusive online event dedicated to accelerating, optimising and decarbonising contract manufacturing. 👉 Register here for your free ticket: https://lnkd.in/eNB_vxzm #CDMO #GLP1

E-Beam and X-Ray sterilization, with its superior penetration characteristics, processing flexibility, and regulatory acceptance, emerges as an advantageous method for terminal sterilization of dense drug products, providing a viable alternative to Gamma techniques in terms of efficiency, safety, and cost-effectiveness. Learn more from MediZap: https://ow.ly/yHNm50QJBpX

IN PRESS: KCentra and Andexxa both show similar efficacy and safety in a multicenter, retrospective chart review for all DOAC-associated major bleedings. #Pharmacists #ForPharmacy https://lnkd.in/eD-4Se6q

Points to consider for sterile filling and more! Agenda is published: https://lnkd.in/eeEjyk_U

Check out ”Intravenous critical care medications preparation during Hajj mass gathering: A review article.” Namareq Aldardeer The paper is accessible via the following link: https://lnkd.in/eVBcvXTz. #clinicalresearch #pharmacy #MENA

Compound Name - Rabeprazole CAT. No. R010000 CAS. No. 117976-89-3 Mol. F. C18H21N3O3S Mol. Wt. 359.43 Stock Status In stock https://lnkd.in/dYFHzm5r #pharmaceuticals #pharmaindustry #pharmaceutical #clinicalresearch #clinical #clinicalstudies #clinicaldevelopment# regulatoryaffairs #analyticalchemistry #bioanalytical #bioanalysis #pharmaceuticalmanufacturing #pharmacology #pharmamarketing #pharmaceuticalcompanies #pharmainnovation #pharmacovigilance #analyticaldevelopment #analysts #regulatoryupdates #cro #impurities #metabolites #stableisotopes Kindly send your enquiry on intl.cro@simsonpharma.com

Another successful Pre-Filled Syringe and Injectable Drug Devices Conference in the books! 🎉 From innovative new technologies to insightful discussions, we covered it all. Can't wait to see what next year brings! #SAEmediagroup #rfid #CCLHealthcare 🌟💉🔬

X-ray irradiation offers sterilization, decontamination, and material modification for #MedicalDevices and #Pharmaceuticals by providing excellent, uniform penetration and efficient processing. Want to learn more? Check out one of our most viewed TechTalks, featuring STERIS Directors of Radiation Technology Deepak Patil and Herve Michel, here: https://lnkd.in/gdMWBAMY WHAT’S COVERED: 🔍The science behind X-ray irradiation 💊Diverse applications involving X-ray irradiation 📊X-ray irradiation in comparison to other radiation technologies BENEFITS OF X-RAY IRRADIATION: ✅Compliance with ISO 11137 standard 🤝Support for product trials, dose establishment, & dose verification 👨🔬Start-to-finish support & guidance from a designated Radiation TechTeam® Project Manager #Sterilization #Decontamination

📅 It's #leapday, an extra day to get organized and pre-register for Asembia's AXS24 Summit. What are you waiting for? - www.asembiasummit.com #specialtypharmacy #pharmacy #marketaccess #pharma #liveevents #healthcareconference #registernow

During this fireside chat, dive into one of the high-risk factors for a containment control strategy (CCS), Annex 1 and Transfers. Richard Denk and Jason Collins, AIA will dive into transfer requirements with examples provided on different cleanroom zones and transfers into barrier. Register for this complimentary webinar: https://hubs.ly/Q02wW-r60 #ISPE #pharma #annex1